The following is a continuation of all our recent MindMed coverage.

It all began with a two-part interview with Dr. Scott Freeman last month.

An Interview with Jake Freeman

As the MindMed ($MNMD) drama continues to unfold, Adam Tubero sat down with Jake Freeman of Freeman Capital. For reference, Jake Freeman is Dr. Scott Freeman’s son and has recently made headlines alongside the Bed Bath & Beyond stock.

A lot is discussed and uncovered in the video below.

As always, please like and subscribe to the Psychedelic Invest YouTube channel.